SCHEMBL14701091

SCHEMBL14701091

Cl/N=N/c1ccc(Cl)c(Cl)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.56
TDP1 Q9NUW8 1/20 0.56
HTR3E A5X5Y0 2/20 0.50
HTR3B O95264 2/20 0.50
HTR3A P46098 2/20 0.50
HTR3D Q70Z44 2/20 0.50
HTR3C Q8WXA8 2/20 0.50
KMT2A Q03164 1/20 0.45
ITGB3 P05106 1/20 0.44
ITGAV P06756 1/20 0.44
MAPT P10636 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
POLB P06746 1/20 0.42
THRB P10828 1/20 0.42
AHR P35869 4/20 0.42
TP53 P04637 1/20 0.42
PMM2 O15305 1/20 0.40
MPI P34949 1/20 0.40
IDO1 P14902 1/20 0.39
TSHR P16473 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29375842 0.87 MAPK1 (0.62) MAPK1TDP1HTR3EHTR3BHTR3A
SCHEMBL31576798 0.87 MAPK1 (0.62) MAPK1TDP1HTR3EHTR3BHTR3A
SCHEMBL8759349 0.87 MAPK1 (0.62) MAPK1TDP1HTR3EHTR3BHTR3A
SCHEMBL9129351 0.87 MAPK1 (0.62) MAPK1TDP1HTR3EHTR3BHTR3A
SCHEMBL9495058 0.78 MAPK1 (0.54) MAPK1TDP1HTR3EHTR3BHTR3A
SCHEMBL27817335 0.76 ALDH1A1 (0.55) MAPK1TDP1HTR3EHTR3BHTR3A
SCHEMBL507208 0.75 MAPK1 (0.68) MAPK1TDP1HTR3EHTR3BHTR3A
SCHEMBL31044049 0.75 MAPK1 (0.68) MAPK1TDP1HTR3EHTR3BHTR3A
SCHEMBL10978025 0.75 MAPT (0.61) MAPK1TDP1HTR3EHTR3BHTR3A
SCHEMBL10978028 0.75 MAPT (0.61) MAPK1TDP1HTR3EHTR3BHTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170121285-A1 Selective androgen receptor modulators RADIUS HEALTH INC (US) 2017-05-04 US disclosed
US-20150266821-A1 SELECTIVE ANDROGEN RECEPTOR MODULATORS RADIUS HEALTH INC (US) 2015-09-24 US disclosed
US-8987319-B2 Selective androgen receptor modulators RADIUS HEALTH, INC. (US) 2015-03-24 US disclosed
US-20130041007-A1 Selective Androgen Receptor Modulators RADIUS HEALTH, INC. 2013-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170121285-A1 Selective androgen receptor modulators AR, SHBG, FSHR MAPK1 1483/4885TDP1 4382/4885HTR3E 1849/4885
US-20150266821-A1 SELECTIVE ANDROGEN RECEPTOR MODULATORS AR, SHBG, FSHR MAPK1 1471/4885TDP1 4377/4885HTR3E 1826/4885
US-20130041007-A1 Selective Androgen Receptor Modulators AR, SHBG, GPR119 MAPK1 1874/4885TDP1 4586/4885HTR3E 1667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.